X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (47) 47
cardiac & cardiovascular systems (37) 37
humans (36) 36
cardiovascular (33) 33
male (29) 29
female (28) 28
middle aged (26) 26
aged (21) 21
myocardial infarction (15) 15
peripheral vascular disease (15) 15
abridged index medicus (13) 13
risk factors (13) 13
medicine, general & internal (11) 11
stroke (11) 11
acute coronary syndromes (9) 9
angiography (9) 9
animals (9) 9
double-blind method (9) 9
hematology (9) 9
mortality (9) 9
follow-up studies (8) 8
prospective studies (8) 8
rats (8) 8
risk (8) 8
atrial fibrillation (7) 7
cells, cultured (7) 7
heart attacks (7) 7
ischemia (7) 7
management (7) 7
myocardial infarction - drug therapy (7) 7
patients (7) 7
acute coronary syndrome (6) 6
coronary artery disease (6) 6
myocardial-infarction (6) 6
outcomes (6) 6
treatment outcome (6) 6
cardiovascular diseases (5) 5
cardiovascular diseases - prevention & control (5) 5
care and treatment (5) 5
cerebral infarction (5) 5
drug therapy, combination (5) 5
heart (5) 5
heart attack (5) 5
heart failure (5) 5
nitric oxide synthase type ii (5) 5
prevention (5) 5
rats, sprague-dawley (5) 5
acute coronary syndrome - drug therapy (4) 4
adult (4) 4
analysis (4) 4
angina (4) 4
angina pectoris (4) 4
apoptosis - drug effects (4) 4
association (4) 4
cardiac myocytes (4) 4
cardiac patients (4) 4
cardiovascular disease (4) 4
cardiovascular diseases - mortality (4) 4
death (4) 4
diagnosis (4) 4
guidelines (4) 4
hemorrhage (4) 4
kaplan-meier estimate (4) 4
life sciences (4) 4
myocardium - metabolism (4) 4
nitric oxide (4) 4
obstetrics & gynecology (4) 4
percutaneous coronary intervention (4) 4
research (4) 4
sex factors (4) 4
therapy (4) 4
time factors (4) 4
aged, 80 and over (3) 3
atrial fibrillation - complications (3) 3
atrial fibrillation - drug therapy (3) 3
australia (3) 3
australia - epidemiology (3) 3
bleeding (3) 3
cells (3) 3
diabetes (3) 3
dose-response relationship, drug (3) 3
drug therapy (3) 3
electrocardiography (3) 3
electrocardiography, ambulatory (3) 3
health risk assessment (3) 3
heart - physiology (3) 3
heart diseases (3) 3
human health and pathology (3) 3
incidence (3) 3
myocardial infarction - physiopathology (3) 3
myocardial ischemia - diagnosis (3) 3
myocardial ischemia - epidemiology (3) 3
nitric oxide synthase - physiology (3) 3
oxidative stress (3) 3
patient outcomes (3) 3
pcsk9 (3) 3
predictive value of tests (3) 3
quality of life (3) 3
recurrence (3) 3
reduction (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Apolipoproteins | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 22, pp. 2093 - 2104
Journal Article